Valeur202020212022202320242025Total du passif1.22 B1.21 B1.25 B1.18 B920 M783.8 MTotal des capitaux propres3.4 B3.96 B4.8 B5.98 B6.44 B7.1 BTotal du passif et des capitaux propres4.62 B5.17 B6.04 B7.17 B7.36 B7.88 BDette totale800 M800 M800 M700 M300 M—Dette nette-1.03 B-1.13 B-2.07 B-2.31 B-2.99 B—
United Therapeutics Corporation - Common Stock
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.